alexa
Reach Us +44-1764-910199
Dorsal Hyperpigmentation Secondary to Pegylated Liposomal Doxorubicin | OMICS International
ISSN: 2576-3857
Journal of Oncology Medicine & Practice

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Dorsal Hyperpigmentation Secondary to Pegylated Liposomal Doxorubicin

Seddik Y1*, Barabino AD2, Ruck S2 and Afqir S1

1Medical Oncology Department, University Hospital Mohammed VI, Oujda, Morocco

2Medical Oncology Department, Emile Durkheim Hospital, Epinal, France

*Corresponding Author:
Seddik Y
Medical Oncology Department, University Hospital Mohammed VI
60000, Oujda, Morocco
Tel: +212670205491
E-mail: [email protected]

Received date: November 21, 2016; Accepted date: November 22, 2016; Published date: November 27, 2016

Citation: Seddik Y, Barabino AD, Ruck S, Afqir S (2016) Dorsal Hyperpigmentation Secondary to Pegylated Liposomal Doxorubicin. J Oncol Med & Pract 1:i102.

Copyright: © 2016 Seddik Y. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Oncology Medicine & Practice

Clinical Image

Skin pigmentation disorders secondary to infusion of Pegylated liposomal doxorubicin (PLD) are relatively rare side effects, in comparison with palmoplantar erythrodysesthesia (hand-foot syndrome), hematological toxicities, and neurotoxicity.

It's a 71 year-old patient who is treated for a metastatic ovarian cancer with a palliative regimen based on PLD at the dose of 50 mg/m2 once every 28 days. She presented a dorsal hyperpigmentation after 6 chemotherapy's cycles. This skin toxicity has progressively regressed after the product stop.

currentissue-oncology-medicine-Dorsal-skin-hyperpigmentation

Figure 1: Dorsal skin hyperpigmentation.

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Conferences

Article Usage

  • Total views: 8302
  • [From(publication date):
    December-2016 - Oct 21, 2018]
  • Breakdown by view type
  • HTML page views : 8221
  • PDF downloads : 81
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Business & Management Journals

Ronald

[email protected]line.com

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

https://www.gaziantepescort.info

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version